Increasing prevalence of self-reported HIV preexposure prophylaxis use in published surveys: a systematic review and meta-analysis

AIDS. 2018 Nov 13;32(17):2633-2635. doi: 10.1097/QAD.0000000000001983.

Abstract

: When combining results from all published surveys, about one in nine global study participants (10.7%) reported ever using preexposure prophylaxis (PrEP) by 2017, a significant increase since US FDA approval in 2012 [odds ratio (OR) = 1.6/year, P < 0.00001]. Moreover, nearly one in six US-based study participants (17.3%) and nearly one in four MSM who met the Centers for Disease Control and Prevention's PrEP indications (24.5%) reported ever using PrEP by 2016. The odds of reporting PrEP use are approximately doubling each year (OR = 1.8/year, P < 0.00001; OR = 2.0/year, P < 0.00001).

Publication types

  • Letter
  • Meta-Analysis
  • Systematic Review

MeSH terms

  • Adult
  • Chemoprevention / methods*
  • Chemoprevention / statistics & numerical data*
  • Chemoprevention / trends
  • Drug Utilization*
  • Female
  • HIV Infections / prevention & control*
  • Homosexuality, Male
  • Humans
  • Male
  • Pre-Exposure Prophylaxis / methods*
  • Pre-Exposure Prophylaxis / statistics & numerical data*
  • Pre-Exposure Prophylaxis / trends
  • Self Report
  • United States
  • Young Adult